Vallera R A, Brazer S R
Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
Am J Gastroenterol. 1995 Aug;90(8):1319-21.
We describe a 74-yr-old man with stage III adenocarcinoma of the lung who presented with suspected malignancy-induced secondary achalasia and responded clinically to intrasphincteric injections of botulinum toxin type A (Botox, Allergen Inc., Irvine, CA). We discuss the use of botulinum toxin in this setting, as well as diagnostic strategies to differentiate achalasia from pseudoachalasia.